These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8829717)

  • 1. Cyproheptadine treatment in neuroleptic-induced akathisia.
    Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
    Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
    Fischel T; Hermesh H; Aizenberg D; Zemishlany Z; Munitz H; Benjamini Y; Weizman A
    J Clin Psychopharmacol; 2001 Dec; 21(6):612-5. PubMed ID: 11763011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.
    Lerner V; Bergman J; Statsenko N; Miodownik C
    J Clin Psychiatry; 2004 Nov; 65(11):1550-4. PubMed ID: 15554771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of betaxolol in neuroleptic-induced akathisia.
    Adler LA; Angrist B; Rotrosen J
    Psychiatry Res; 1991 Nov; 39(2):193-8. PubMed ID: 1686812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoria.
    Newcomer JW; Miller LS; Faustman WO; Wetzel MW; Vogler GP; Csernansky JG
    Br J Psychiatry; 1994 Jun; 164(6):834-8. PubMed ID: 7952993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia.
    Poyurovsky M; Weizman A
    Int Clin Psychopharmacol; 1999 Nov; 14(6):357-60. PubMed ID: 10565803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second thoughts about clozapine as a treatment for neuroleptic-induced akathisia.
    Levine J; Chengappa KN
    J Clin Psychiatry; 1998 Apr; 59(4):195. PubMed ID: 9590672
    [No Abstract]   [Full Text] [Related]  

  • 8. Low serum iron in patients with neuroleptic-induced akathisia and dystonia under antipsychotic drug treatment.
    Horiguchi J
    Acta Psychiatr Scand; 1991 Sep; 84(3):301-3. PubMed ID: 1683097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of activation procedures on neuroleptic-induced akathisia.
    Fleischhacker WW; Miller CH; Barnas C; Bergmann K; Perovich R; Alvir JM; Lieberman JA; Kane JM
    Br J Psychiatry; 1993 Dec; 163():781-4. PubMed ID: 7905775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study.
    Miodownik C; Lerner V; Statsenko N; Dwolatzky T; Nemets B; Berzak E; Bergman J
    Clin Neuropharmacol; 2006; 29(2):68-72. PubMed ID: 16614537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mianserin for the rapid improvement of chronic akathisia in a schizophrenia patient.
    Stryjer R; Grupper D; Strous R; Poyurovsky M; Weizman A
    Eur Psychiatry; 2004 Jun; 19(4):237-8. PubMed ID: 15196609
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem.
    Poyurovsky M; Weizman A
    Br J Psychiatry; 2001 Jul; 179():4-8. PubMed ID: 11435260
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of neuroleptic-induced akathisia with the 5-HT2A antagonist trazodone.
    Stryjer R; Strous RD; Bar F; Poyurovsky M; Weizman A; Kotler M
    Clin Neuropharmacol; 2003; 26(3):137-41. PubMed ID: 12782915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin antagonists and neuroleptic-induced extrapyramidal symptoms.
    Poyurovsky M; Weizman A
    Isr J Psychiatry Relat Sci; 1998; 35(1):70-1. PubMed ID: 9615532
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
    Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A
    J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study.
    Gross-Isseroff R; Magen A; Shiloh R; Hermesh H; Weizman A
    Int Clin Psychopharmacol; 2005 Jan; 20(1):23-5. PubMed ID: 15602112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study.
    Poyurovsky M; Shardorodsky M; Fuchs C; Schneidman M; Weizman A
    Br J Psychiatry; 1999 Mar; 174():238-42. PubMed ID: 10448449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.
    Stryjer R; Rosenzcwaig S; Bar F; Ulman AM; Weizman A; Spivak B
    Clin Neuropharmacol; 2010; 33(5):219-22. PubMed ID: 20838215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine for neuroleptic-induced akathisia.
    Poyurovsky M; Weizman A
    Am J Psychiatry; 2001 May; 158(5):819. PubMed ID: 11329417
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonergic agents in the treatment of acute neuroleptic-induced akathisia: open-label study of buspirone and mianserin.
    Poyurovsky M; Weizman A
    Int Clin Psychopharmacol; 1997 Sep; 12(5):263-8. PubMed ID: 9466160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.